PANTHERx Rare Pharmacy is proud to have again earned the #1 ranking in the quarterly patient satisfaction survey conducted by MMIT, an independent national survey entity. For the first quarter of 2022, PANTHERx obtained the highest Net Promoter Score (NPS) among all independent specialty pharmacies surveyed. Net Promoter Score (NPS) is compiled by asking patients, on a scale of 0 to 10, how likely they would be to recommend their specialty pharmacy to a friend or family member. With an NPS of 94 (out of 100), PANTHERx scored 50% higher than the industry average.
“At PANTHERx, we pride ourselves on providing superior services and white-glove care to all of the people we serve. The MMIT Patient Satisfaction survey allows us to quantitatively confirm quarter after quarter that our patients are feeling the work that our associates put forth and are satisfied with our efforts to deliver the best possible experiences,” said Rob Snyder, President of PANTHERx Rare. “I would like to thank and congratulate our associates for their extraordinary daily contributions to our company, the people and families we support, and the rare disease community.”
The PANTHERx team is honored to be held in such high regard by our patients. The critical feedback afforded by the MMIT Patient Satisfaction survey allows PANTHERx to measure success and adjust our programs to the needs and desires of the patients we serve. Data from the 2022 Q1 results illustrate:
- 100% of patients surveyed indicated that they are satisfied with medication fill and refill times
- 100% of patients surveyed indicated that they are satisfied with the amount of time it takes to speak with a live person, putting PANTHERx in the lead in this category when compared to the other 10 participating independent specialty pharmacies
- when patients were asked how they would feel if forced to change specialty pharmacies, 93% responded that they would be very unhappy
- Surveyed patients note PANTHERx key differentiators as: refill reminders, amazing service, and professional and knowledgeable
About PANTHERx Rare
PANTHERx Rare is one of the largest and fastest growing rare pharmacies in the United States. PANTHERx transforms lives by delivering medicine breakthroughs, clinical excellence, and access solutions to people living with rare and devastating conditions. Although the overall incidence of rare diseases is as common as diabetes, less than 7% of the 7,000 known rare and devastating disorders have an FDA-approved therapy. Changes in federal policy and advances in science have led to a surge in FDA orphan drug approvals, providing tremendous hope to the rare disease community.
PANTHERx was recently awarded Specialty Pharmacy of the Year by the National Association of Specialty Pharmacy (NASP) and earned the inaugural Accredited Distinction in Rare Diseases and Orphan Drugs from the Accreditation Commission for Health Care (ACHC). PANTHERx is a five-time winner of the prestigious MMIT Patient Choice Award, including the 2022 honor. PANTHERx is headquartered in Pittsburgh, Pennsylvania, licensed in all 50 states, and holds accreditations from URAC, NABP, and ACHC.